Aim: Niacin and fenofibrate are to date the most effective available HDL-C raising therapies. We examined the effects of niacin extended-release (ER) and fenofibrate treatment on endothelial function. Methods: In a multicenter, randomized, open-label, cross-over study, dyslipidemic subjects were included; 24 with low HDL-C (<40 mg/dL) and 42 with normal HDL-C (40-59 mg/dL) at baseline, received 6 weeks’ treatment with niacin ER (0.5 g/d then 1 g/d) and fenofibrate (160 mg/d) with 4 weeks’ wash-out between treatments. Lipoprotein composition and particle size distribution were determined using NMR. Endothelial function was assessed by ultrasound brachial flow mediated dilatation (FMD) at start and end of the 6 week treatment periods. Between treatment effects were compared using ANCOVA. In slope analyses within treatments, each of the lipids and lipoproteins were correlated with %FMD, both at baseline and at end of treatment Results: Complete FMD datasets of 19 niacin ER and 17 fenofibrate treatments were available. There was no difference in FMD between treatments (p>0.2). The slope analyses, however, showed correlations between lipids and FMD, the strongest correlations occurred in the niacin ER group. In particular HDL-C (p=0.032), HDL particle size (p=0.009) and LDL sizes correlated with FMD upon niacin ER treatment. Conclusions: There were no differential effects between niacin ER and fenofibrate on endothelial function, however slope analyses revealed lipid modification by niacin ER and (to a lesser extent) fenofibrate can favorably improve endothelial function.

Effects of Niacin Extended-Release and Fenofibrate on Endothelial Function / E. de Groot, D. Baldassarre, K. Coutant, E.J. Niesor, F. Lamour, R. Benghozi. ((Intervento presentato al 80. convegno EAS CONGRESS SATELLITE SYMPOSIUM – HIGH DENSITY LIPORPROTEINS: FROM BASIC SCIENCE TO THERAPEUTIC ADVANCES tenutosi a Milano nel 2012.

Effects of Niacin Extended-Release and Fenofibrate on Endothelial Function

D. Baldassarre
Secondo
;
2012

Abstract

Aim: Niacin and fenofibrate are to date the most effective available HDL-C raising therapies. We examined the effects of niacin extended-release (ER) and fenofibrate treatment on endothelial function. Methods: In a multicenter, randomized, open-label, cross-over study, dyslipidemic subjects were included; 24 with low HDL-C (<40 mg/dL) and 42 with normal HDL-C (40-59 mg/dL) at baseline, received 6 weeks’ treatment with niacin ER (0.5 g/d then 1 g/d) and fenofibrate (160 mg/d) with 4 weeks’ wash-out between treatments. Lipoprotein composition and particle size distribution were determined using NMR. Endothelial function was assessed by ultrasound brachial flow mediated dilatation (FMD) at start and end of the 6 week treatment periods. Between treatment effects were compared using ANCOVA. In slope analyses within treatments, each of the lipids and lipoproteins were correlated with %FMD, both at baseline and at end of treatment Results: Complete FMD datasets of 19 niacin ER and 17 fenofibrate treatments were available. There was no difference in FMD between treatments (p>0.2). The slope analyses, however, showed correlations between lipids and FMD, the strongest correlations occurred in the niacin ER group. In particular HDL-C (p=0.032), HDL particle size (p=0.009) and LDL sizes correlated with FMD upon niacin ER treatment. Conclusions: There were no differential effects between niacin ER and fenofibrate on endothelial function, however slope analyses revealed lipid modification by niacin ER and (to a lesser extent) fenofibrate can favorably improve endothelial function.
Settore BIO/14 - Farmacologia
European Atherosclerosis Society
Effects of Niacin Extended-Release and Fenofibrate on Endothelial Function / E. de Groot, D. Baldassarre, K. Coutant, E.J. Niesor, F. Lamour, R. Benghozi. ((Intervento presentato al 80. convegno EAS CONGRESS SATELLITE SYMPOSIUM – HIGH DENSITY LIPORPROTEINS: FROM BASIC SCIENCE TO THERAPEUTIC ADVANCES tenutosi a Milano nel 2012.
Conference Object
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/203177
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact